TITLE

Perindopril reduced cardiac events in stable coronary artery disease: COMMENTARY

AUTHOR(S)
Best, Patricia J. M.; Berger, Peter R.
PUB. DATE
March 2004
SOURCE
ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article comments on the study of the efficacy of perindopril in reducing cardiac event in stable coronary artery diseases. The supported the widespread use of the angiotensin-converting enzyme (ACE ) inhibitor ramipril to prevent cardiovascular events. However, several questions remained and many physicians had reservations about changing practice based on a single, albeit large and well-designed, study. Even clinicians who believe that the benefits of ACE inhibitors are a class effect and not unique to tissue-specific ACE inhibitors acknowledge that the right dose and dosing strategy must be identified for each indication before it is assumed that all ACE inhibitors are equal.
ACCESSION #
12597113

 

Related Articles

  • Perindopril reduced cardiac events in stable coronary artery disease.  // ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, p31 

    The article focuses on the factors that help in reducing the cardiovascular events among patients with stable coronary artery disease. It examines if the angiotensin-converting enzyme (ACE) inhibitor perindopril reduce cardiac events in patients with stable coronary artery disease (CAD)....

  • ACE Inhibitors after Myocardial Infarction: Clinical and Economic Considerations. Davie, A.P. // PharmacoEconomics;2000, Vol. 17 Issue 3, p237 

    Economic analysis has been extensively used to guide the use of ACE inhibitors in chronic heart failure. More recently, it has been used to guide the use of ACE inhibitors after myocardial infarction. The results of major clinical trials leave us in no doubt that ACE inhibitors are useful in the...

  • Interaction Between Aspirin and ACE Inhibitors: Resolving Discrepancies Using a Meta-Analysis. Takkouche, B.; Etminan, M.; Caamaño, F.; Rochon, P.A. // Drug Safety;Mar2002, Vol. 25 Issue 5, p373 

    Background: Recently, studies have attempted to explore the interaction between ACE inhibitors and aspirin (acetylsalicylic acid) when both drugs are used concomitantly to reduce mortality in patients with coronary artery disease. Results have been conflicting due, in part, to sub-optimal...

  • Cardiology.  // Current Medical Literature: Health Care of Older People;2003, Vol. 16 Issue 2, p47 

    Presents citations and clinicians' notes about geriatric cardiology. Arterial stiffness in postmenopausal women; Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications.

  • Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics. Murphy, B.F.; Whitworth, Judith A.; Kincaid-Smith, Priscilla // British Medical Journal (Clinical Research Edition);3/17/1984, Vol. 288 Issue 6420, p844 

    Reports a case study on the use of angiotensin converting enzyme inhibitors and diuretics on a patient with bilateral renal artery stenosis in Great Britain. Examination of a patient experiencing headache and blurred vision; Diagnosis of the disease; Treatment of the disease.

  • A Comparative Study of Captopril and Enalapril on Endothelial Cell Function in Congestive Heart Failure Patients. Bridges, A. B.; McLaren, M.; Belch, J. J. F. // Angiology;Sep1995, Vol. 46 Issue 9, p811 

    Angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce the incidence of future coronary artery thromboses in postmyocardial infarction patients. A possible prothrombotic role for the angiotensin system has been postulated, and support for this has been provided by a recent...

  • Combination Therapy with Angiotensin Converting Enzyme Inhibition and AT1 Receptor Inhibitor on Ventricular Remodeling After Myocardial Infarction in Rats. Zornoff, Leonardo A. M.; Paiva, S�rgio A. R.; Matsubara, Beatriz B.; Matsubara, Luiz B.; Spadaro, Joel // Journal of Cardiovascular Pharmacology & Therapeutics;Sep2000, Vol. 5 Issue 3, p203 

    The article discusses the results of a study comparing the combined administration of angiotensin converting enzyme (ACE) inhibitor and angiotensin II type I (AT, 1 ) receptor antagonist against the drugs' individual effects. It is noted that the study was conducted on rats that suffered from...

  • ACE inhibitors in CHF: Are higher dosages better? Pinkowish, Mary Desmond // Patient Care;6/15/1998, Vol. 32 Issue 11, p233 

    Focuses on the use of angiotensin converting enzyme (ACE) inhibitors in coronary heart failure (CHF), while highlighting a study entitled `Assessment of Treatment with Lisinopril and Survival (ATLAS),' by M. Packer which was presented at the American College of Cardiology 47th Annual Scientific...

  • Study: Inexpensive Four-Drug Combo Saves Heart Patients' Lives; 90 Percent Cut in Death Risk From Aspirin, Beta Blocker, ACE Inhibitor, Statin.  // Ascribe Newswire: Medicine;2/19/2004, p8 

    This article reports that heart attack and unstable angina patients who were prescribed all four types of proven medications had a 90 percent lower risk of dying in the six months after they left the hospital than those who received none of the drugs. The four classes of medications are:...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics